1. Select Therapeutic Target
Indication Profile2. Optical & Temporal Parameters
Calibration
Wavelength (λ)
810 nm
Target Irradiance
50 mW/cm²
Power flux arriving at target tissue
Session Duration
15 min
Cumulative exposure time per session
Emitter Distance
15 cm
Inverse square law dissipation factor
Pulsing Frequency (Hz) & Neuromodulation
40 Hz
3. Photon Penetration & CCO Absorption
Transcranial Model
Tissue Depth: 0 – 35 mm
Photons
Cytochrome c Oxidase
⚡ Photon density activating mitochondrial complex IV (Cytochrome c oxidase).
Clinical Dose Calculation
45.0
J/cm² (Total Fluence)
Therapeutic Window: Optimal Clinical Range (10 – 60 J/cm²) based on the biphasic Arndt-Schulz law.
Evidence Tier
Emerging Clinical & Pre-Clinical
Penetration Rating
Deep Tissue / Transcranial
Primary Mechanism
Cytochrome c oxidase activation & 40Hz gamma microglial stimulation
Recommended Frequency
3-5x weekly
7-day clinical routine optimized for biological circadian rhythm and cellular recovery intervals:
| Day | Status | Target & Distance | Dose & Time |
|---|
Safety & Compliance Notes:
- Wear optical density (OD4+) laser/LED goggles during facial, cranial, or retinal vicinity exposures.
- Maintain consistent distance to avoid exponential inverse-square power falloff.
- Do not exceed 100 J/cm² per session to prevent biphasic photobiomodulation inhibition.
Scientific Context & Disclaimers
Photobiomodulation (PBM) stimulates mitochondrial electron transport chains via Cytochrome c Oxidase (Unit IV). Transcranial Near-Infrared Light (tPBM at 810–1064nm) penetrates bone and meninges to stimulate cortical neurons, while 40Hz pulsed light entrains microglia for neurodegenerative plaque clearance. Information is for research education and dosing calculation, not prescriptive medical advice.